nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Device related infection—Fluorouracil—head and neck cancer	0.0419	0.0419	CcSEcCtD
Valganciclovir—Edema of lower extremities—Docetaxel—head and neck cancer	0.0261	0.0261	CcSEcCtD
Valganciclovir—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.0159	0.0159	CcSEcCtD
Valganciclovir—Bone marrow depression—Hydroxyurea—head and neck cancer	0.0149	0.0149	CcSEcCtD
Valganciclovir—Ascites—Docetaxel—head and neck cancer	0.0115	0.0115	CcSEcCtD
Valganciclovir—Neoplasm—Vinblastine—head and neck cancer	0.01	0.01	CcSEcCtD
Valganciclovir—Phlebitis—Vinblastine—head and neck cancer	0.00932	0.00932	CcSEcCtD
Valganciclovir—Neoplasm—Hydroxyurea—head and neck cancer	0.00912	0.00912	CcSEcCtD
Valganciclovir—Deafness—Vinblastine—head and neck cancer	0.00898	0.00898	CcSEcCtD
Valganciclovir—Oral candidiasis—Docetaxel—head and neck cancer	0.00825	0.00825	CcSEcCtD
Valganciclovir—Leukocytosis—Fluorouracil—head and neck cancer	0.00773	0.00773	CcSEcCtD
Valganciclovir—Throat sore—Docetaxel—head and neck cancer	0.00727	0.00727	CcSEcCtD
Valganciclovir—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00721	0.00721	CcSEcCtD
Valganciclovir—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00686	0.00686	CcSEcCtD
Valganciclovir—Pleural effusion—Docetaxel—head and neck cancer	0.00684	0.00684	CcSEcCtD
Valganciclovir—Oesophagitis—Fluorouracil—head and neck cancer	0.00664	0.00664	CcSEcCtD
Valganciclovir—Coma—Fluorouracil—head and neck cancer	0.00664	0.00664	CcSEcCtD
Valganciclovir—Pancytopenia—Vinblastine—head and neck cancer	0.00659	0.00659	CcSEcCtD
Valganciclovir—Rhinorrhoea—Docetaxel—head and neck cancer	0.00647	0.00647	CcSEcCtD
Valganciclovir—Rigors—Docetaxel—head and neck cancer	0.00642	0.00642	CcSEcCtD
Valganciclovir—Sepsis—Fluorouracil—head and neck cancer	0.0063	0.0063	CcSEcCtD
Valganciclovir—Pancreatitis—Hydroxyurea—head and neck cancer	0.00621	0.00621	CcSEcCtD
Valganciclovir—Depression—Vinblastine—head and neck cancer	0.00617	0.00617	CcSEcCtD
Valganciclovir—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00609	0.00609	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00607	0.00607	CcSEcCtD
Valganciclovir—Pancytopenia—Hydroxyurea—head and neck cancer	0.00601	0.00601	CcSEcCtD
Valganciclovir—Dysuria—Hydroxyurea—head and neck cancer	0.00592	0.00592	CcSEcCtD
Valganciclovir—Neutropenia—Hydroxyurea—head and neck cancer	0.00592	0.00592	CcSEcCtD
Valganciclovir—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00576	0.00576	CcSEcCtD
Valganciclovir—Infestation—Hydroxyurea—head and neck cancer	0.00564	0.00564	CcSEcCtD
Valganciclovir—Infestation NOS—Hydroxyurea—head and neck cancer	0.00564	0.00564	CcSEcCtD
Valganciclovir—Amnesia—Fluorouracil—head and neck cancer	0.00561	0.00561	CcSEcCtD
Valganciclovir—Haemoglobin—Vinblastine—head and neck cancer	0.00558	0.00558	CcSEcCtD
Valganciclovir—Haemorrhage—Vinblastine—head and neck cancer	0.00556	0.00556	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00553	0.00553	CcSEcCtD
Valganciclovir—Pharyngitis—Vinblastine—head and neck cancer	0.00551	0.00551	CcSEcCtD
Valganciclovir—Stomatitis—Hydroxyurea—head and neck cancer	0.0055	0.0055	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00534	0.00534	CcSEcCtD
Valganciclovir—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00527	0.00527	CcSEcCtD
Valganciclovir—Haemoglobin—Hydroxyurea—head and neck cancer	0.00509	0.00509	CcSEcCtD
Valganciclovir—Influenza like illness—Docetaxel—head and neck cancer	0.00509	0.00509	CcSEcCtD
Valganciclovir—Haemorrhage—Hydroxyurea—head and neck cancer	0.00507	0.00507	CcSEcCtD
Valganciclovir—Hallucination—Hydroxyurea—head and neck cancer	0.00504	0.00504	CcSEcCtD
Valganciclovir—Candida infection—Docetaxel—head and neck cancer	0.005	0.005	CcSEcCtD
Valganciclovir—Ataxia—Fluorouracil—head and neck cancer	0.00496	0.00496	CcSEcCtD
Valganciclovir—Alopecia—Vinblastine—head and neck cancer	0.00491	0.00491	CcSEcCtD
Valganciclovir—Dry skin—Fluorouracil—head and neck cancer	0.00483	0.00483	CcSEcCtD
Valganciclovir—Oesophagitis—Docetaxel—head and neck cancer	0.00479	0.00479	CcSEcCtD
Valganciclovir—Neoplasm—Docetaxel—head and neck cancer	0.00474	0.00474	CcSEcCtD
Valganciclovir—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00471	0.00471	CcSEcCtD
Valganciclovir—Angiopathy—Hydroxyurea—head and neck cancer	0.0046	0.0046	CcSEcCtD
Valganciclovir—Dysphagia—Fluorouracil—head and neck cancer	0.00456	0.00456	CcSEcCtD
Valganciclovir—Sepsis—Docetaxel—head and neck cancer	0.00455	0.00455	CcSEcCtD
Valganciclovir—Chills—Hydroxyurea—head and neck cancer	0.00455	0.00455	CcSEcCtD
Valganciclovir—Eosinophilia—Fluorouracil—head and neck cancer	0.00451	0.00451	CcSEcCtD
Valganciclovir—Ill-defined disorder—Vinblastine—head and neck cancer	0.00449	0.00449	CcSEcCtD
Valganciclovir—Alopecia—Hydroxyurea—head and neck cancer	0.00448	0.00448	CcSEcCtD
Valganciclovir—Anaemia—Vinblastine—head and neck cancer	0.00447	0.00447	CcSEcCtD
Valganciclovir—Phlebitis—Docetaxel—head and neck cancer	0.00442	0.00442	CcSEcCtD
Valganciclovir—Thrombophlebitis—Docetaxel—head and neck cancer	0.0044	0.0044	CcSEcCtD
Valganciclovir—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00437	0.00437	CcSEcCtD
Valganciclovir—Malaise—Vinblastine—head and neck cancer	0.00436	0.00436	CcSEcCtD
Valganciclovir—Vertigo—Vinblastine—head and neck cancer	0.00435	0.00435	CcSEcCtD
Valganciclovir—Leukopenia—Vinblastine—head and neck cancer	0.00433	0.00433	CcSEcCtD
Valganciclovir—Pancytopenia—Fluorouracil—head and neck cancer	0.00433	0.00433	CcSEcCtD
Valganciclovir—Deafness—Docetaxel—head and neck cancer	0.00425	0.00425	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00423	0.00423	CcSEcCtD
Valganciclovir—Convulsion—Vinblastine—head and neck cancer	0.00419	0.00419	CcSEcCtD
Valganciclovir—Hypertension—Vinblastine—head and neck cancer	0.00418	0.00418	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00416	0.00416	CcSEcCtD
Valganciclovir—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00409	0.00409	CcSEcCtD
Valganciclovir—Pneumonia—Fluorouracil—head and neck cancer	0.00409	0.00409	CcSEcCtD
Valganciclovir—Anaemia—Hydroxyurea—head and neck cancer	0.00408	0.00408	CcSEcCtD
Valganciclovir—Discomfort—Vinblastine—head and neck cancer	0.00407	0.00407	CcSEcCtD
Valganciclovir—Infestation—Fluorouracil—head and neck cancer	0.00406	0.00406	CcSEcCtD
Valganciclovir—Infestation NOS—Fluorouracil—head and neck cancer	0.00406	0.00406	CcSEcCtD
Valganciclovir—Renal impairment—Docetaxel—head and neck cancer	0.004	0.004	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00398	0.00398	CcSEcCtD
Valganciclovir—Malaise—Hydroxyurea—head and neck cancer	0.00398	0.00398	CcSEcCtD
Valganciclovir—Stomatitis—Fluorouracil—head and neck cancer	0.00396	0.00396	CcSEcCtD
Valganciclovir—Urinary tract infection—Fluorouracil—head and neck cancer	0.00395	0.00395	CcSEcCtD
Valganciclovir—Leukopenia—Hydroxyurea—head and neck cancer	0.00395	0.00395	CcSEcCtD
Valganciclovir—Thrombocytopenia—Vinblastine—head and neck cancer	0.00386	0.00386	CcSEcCtD
Valganciclovir—Convulsion—Hydroxyurea—head and neck cancer	0.00382	0.00382	CcSEcCtD
Valganciclovir—Sinusitis—Fluorouracil—head and neck cancer	0.00381	0.00381	CcSEcCtD
Valganciclovir—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00381	0.00381	CcSEcCtD
Valganciclovir—Pain in extremity—Docetaxel—head and neck cancer	0.00381	0.00381	CcSEcCtD
Valganciclovir—Anorexia—Vinblastine—head and neck cancer	0.00376	0.00376	CcSEcCtD
Valganciclovir—Migraine—Docetaxel—head and neck cancer	0.00375	0.00375	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00373	0.00373	CcSEcCtD
Valganciclovir—Discomfort—Hydroxyurea—head and neck cancer	0.00371	0.00371	CcSEcCtD
Valganciclovir—Haemoglobin—Fluorouracil—head and neck cancer	0.00367	0.00367	CcSEcCtD
Valganciclovir—Haemorrhage—Fluorouracil—head and neck cancer	0.00365	0.00365	CcSEcCtD
Valganciclovir—Pharyngitis—Fluorouracil—head and neck cancer	0.00362	0.00362	CcSEcCtD
Valganciclovir—Oedema—Hydroxyurea—head and neck cancer	0.0036	0.0036	CcSEcCtD
Valganciclovir—Ataxia—Docetaxel—head and neck cancer	0.00358	0.00358	CcSEcCtD
Valganciclovir—Infection—Hydroxyurea—head and neck cancer	0.00358	0.00358	CcSEcCtD
Valganciclovir—Paraesthesia—Vinblastine—head and neck cancer	0.00354	0.00354	CcSEcCtD
Valganciclovir—Dehydration—Docetaxel—head and neck cancer	0.00354	0.00354	CcSEcCtD
Valganciclovir—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00353	0.00353	CcSEcCtD
Valganciclovir—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00352	0.00352	CcSEcCtD
Valganciclovir—Skin disorder—Hydroxyurea—head and neck cancer	0.0035	0.0035	CcSEcCtD
Valganciclovir—Dry skin—Docetaxel—head and neck cancer	0.00349	0.00349	CcSEcCtD
Valganciclovir—Abdominal pain upper—Docetaxel—head and neck cancer	0.00348	0.00348	CcSEcCtD
Valganciclovir—Anorexia—Hydroxyurea—head and neck cancer	0.00343	0.00343	CcSEcCtD
Valganciclovir—Decreased appetite—Vinblastine—head and neck cancer	0.00343	0.00343	CcSEcCtD
Valganciclovir—Cramp muscle—Docetaxel—head and neck cancer	0.00343	0.00343	CcSEcCtD
Valganciclovir—Nasopharyngitis—Docetaxel—head and neck cancer	0.0034	0.0034	CcSEcCtD
Valganciclovir—Pain—Vinblastine—head and neck cancer	0.00338	0.00338	CcSEcCtD
Valganciclovir—Constipation—Vinblastine—head and neck cancer	0.00338	0.00338	CcSEcCtD
Valganciclovir—Dysphagia—Docetaxel—head and neck cancer	0.00329	0.00329	CcSEcCtD
Valganciclovir—Arrhythmia—Fluorouracil—head and neck cancer	0.00326	0.00326	CcSEcCtD
Valganciclovir—Feeling abnormal—Vinblastine—head and neck cancer	0.00325	0.00325	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00323	0.00323	CcSEcCtD
Valganciclovir—Alopecia—Fluorouracil—head and neck cancer	0.00322	0.00322	CcSEcCtD
Valganciclovir—Dyspnoea—Hydroxyurea—head and neck cancer	0.00321	0.00321	CcSEcCtD
Valganciclovir—Somnolence—Hydroxyurea—head and neck cancer	0.0032	0.0032	CcSEcCtD
Valganciclovir—Dyspepsia—Hydroxyurea—head and neck cancer	0.00317	0.00317	CcSEcCtD
Valganciclovir—Decreased appetite—Hydroxyurea—head and neck cancer	0.00313	0.00313	CcSEcCtD
Valganciclovir—Pancytopenia—Docetaxel—head and neck cancer	0.00312	0.00312	CcSEcCtD
Valganciclovir—Abdominal pain—Vinblastine—head and neck cancer	0.00312	0.00312	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00311	0.00311	CcSEcCtD
Valganciclovir—Fatigue—Hydroxyurea—head and neck cancer	0.0031	0.0031	CcSEcCtD
Valganciclovir—Pain—Hydroxyurea—head and neck cancer	0.00308	0.00308	CcSEcCtD
Valganciclovir—Constipation—Hydroxyurea—head and neck cancer	0.00308	0.00308	CcSEcCtD
Valganciclovir—Neutropenia—Docetaxel—head and neck cancer	0.00308	0.00308	CcSEcCtD
Valganciclovir—Vision blurred—Fluorouracil—head and neck cancer	0.00299	0.00299	CcSEcCtD
Valganciclovir—Weight decreased—Docetaxel—head and neck cancer	0.00298	0.00298	CcSEcCtD
Valganciclovir—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00297	0.00297	CcSEcCtD
Valganciclovir—Pneumonia—Docetaxel—head and neck cancer	0.00295	0.00295	CcSEcCtD
Valganciclovir—Anaemia—Fluorouracil—head and neck cancer	0.00293	0.00293	CcSEcCtD
Valganciclovir—Infestation NOS—Docetaxel—head and neck cancer	0.00293	0.00293	CcSEcCtD
Valganciclovir—Infestation—Docetaxel—head and neck cancer	0.00293	0.00293	CcSEcCtD
Valganciclovir—Hypersensitivity—Vinblastine—head and neck cancer	0.00291	0.00291	CcSEcCtD
Valganciclovir—Renal failure—Docetaxel—head and neck cancer	0.00288	0.00288	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00287	0.00287	CcSEcCtD
Valganciclovir—Jaundice—Docetaxel—head and neck cancer	0.00286	0.00286	CcSEcCtD
Valganciclovir—Stomatitis—Docetaxel—head and neck cancer	0.00286	0.00286	CcSEcCtD
Valganciclovir—Body temperature increased—Hydroxyurea—head and neck cancer	0.00285	0.00285	CcSEcCtD
Valganciclovir—Leukopenia—Fluorouracil—head and neck cancer	0.00284	0.00284	CcSEcCtD
Valganciclovir—Asthenia—Vinblastine—head and neck cancer	0.00283	0.00283	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00277	0.00277	CcSEcCtD
Valganciclovir—Convulsion—Fluorouracil—head and neck cancer	0.00275	0.00275	CcSEcCtD
Valganciclovir—Diarrhoea—Vinblastine—head and neck cancer	0.0027	0.0027	CcSEcCtD
Valganciclovir—Discomfort—Fluorouracil—head and neck cancer	0.00267	0.00267	CcSEcCtD
Valganciclovir—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00265	0.00265	CcSEcCtD
Valganciclovir—Haemoglobin—Docetaxel—head and neck cancer	0.00265	0.00265	CcSEcCtD
Valganciclovir—Haemorrhage—Docetaxel—head and neck cancer	0.00263	0.00263	CcSEcCtD
Valganciclovir—Hepatitis—Docetaxel—head and neck cancer	0.00263	0.00263	CcSEcCtD
Valganciclovir—Confusional state—Fluorouracil—head and neck cancer	0.00261	0.00261	CcSEcCtD
Valganciclovir—Pharyngitis—Docetaxel—head and neck cancer	0.00261	0.00261	CcSEcCtD
Valganciclovir—Dizziness—Vinblastine—head and neck cancer	0.00261	0.00261	CcSEcCtD
Valganciclovir—Urinary tract disorder—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Valganciclovir—Oedema peripheral—Docetaxel—head and neck cancer	0.00259	0.00259	CcSEcCtD
Valganciclovir—Oedema—Fluorouracil—head and neck cancer	0.00259	0.00259	CcSEcCtD
Valganciclovir—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00259	0.00259	CcSEcCtD
Valganciclovir—Connective tissue disorder—Docetaxel—head and neck cancer	0.00259	0.00259	CcSEcCtD
Valganciclovir—Asthenia—Hydroxyurea—head and neck cancer	0.00258	0.00258	CcSEcCtD
Valganciclovir—Urethral disorder—Docetaxel—head and neck cancer	0.00258	0.00258	CcSEcCtD
Valganciclovir—Infection—Fluorouracil—head and neck cancer	0.00257	0.00257	CcSEcCtD
Valganciclovir—Nervous system disorder—Fluorouracil—head and neck cancer	0.00254	0.00254	CcSEcCtD
Valganciclovir—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00254	0.00254	CcSEcCtD
Valganciclovir—Visual impairment—Docetaxel—head and neck cancer	0.00254	0.00254	CcSEcCtD
Valganciclovir—Tachycardia—Fluorouracil—head and neck cancer	0.00253	0.00253	CcSEcCtD
Valganciclovir—Vomiting—Vinblastine—head and neck cancer	0.00251	0.00251	CcSEcCtD
Valganciclovir—Headache—Vinblastine—head and neck cancer	0.00247	0.00247	CcSEcCtD
Valganciclovir—Anorexia—Fluorouracil—head and neck cancer	0.00247	0.00247	CcSEcCtD
Valganciclovir—Diarrhoea—Hydroxyurea—head and neck cancer	0.00246	0.00246	CcSEcCtD
Valganciclovir—Eye disorder—Docetaxel—head and neck cancer	0.00246	0.00246	CcSEcCtD
Valganciclovir—Cardiac disorder—Docetaxel—head and neck cancer	0.00244	0.00244	CcSEcCtD
Valganciclovir—Hypotension—Fluorouracil—head and neck cancer	0.00242	0.00242	CcSEcCtD
Valganciclovir—Angiopathy—Docetaxel—head and neck cancer	0.00239	0.00239	CcSEcCtD
Valganciclovir—Dizziness—Hydroxyurea—head and neck cancer	0.00238	0.00238	CcSEcCtD
Valganciclovir—Immune system disorder—Docetaxel—head and neck cancer	0.00238	0.00238	CcSEcCtD
Valganciclovir—Mediastinal disorder—Docetaxel—head and neck cancer	0.00237	0.00237	CcSEcCtD
Valganciclovir—Chills—Docetaxel—head and neck cancer	0.00236	0.00236	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00236	0.00236	CcSEcCtD
Valganciclovir—Arrhythmia—Docetaxel—head and neck cancer	0.00235	0.00235	CcSEcCtD
Valganciclovir—Nausea—Vinblastine—head and neck cancer	0.00234	0.00234	CcSEcCtD
Valganciclovir—Insomnia—Fluorouracil—head and neck cancer	0.00234	0.00234	CcSEcCtD
Valganciclovir—Paraesthesia—Fluorouracil—head and neck cancer	0.00233	0.00233	CcSEcCtD
Valganciclovir—Alopecia—Docetaxel—head and neck cancer	0.00233	0.00233	CcSEcCtD
Valganciclovir—Dyspnoea—Fluorouracil—head and neck cancer	0.00231	0.00231	CcSEcCtD
Valganciclovir—Mental disorder—Docetaxel—head and neck cancer	0.00231	0.00231	CcSEcCtD
Valganciclovir—Somnolence—Fluorouracil—head and neck cancer	0.0023	0.0023	CcSEcCtD
Valganciclovir—Malnutrition—Docetaxel—head and neck cancer	0.00229	0.00229	CcSEcCtD
Valganciclovir—Vomiting—Hydroxyurea—head and neck cancer	0.00229	0.00229	CcSEcCtD
Valganciclovir—Dyspepsia—Fluorouracil—head and neck cancer	0.00228	0.00228	CcSEcCtD
Valganciclovir—Dermatitis—Hydroxyurea—head and neck cancer	0.00227	0.00227	CcSEcCtD
Valganciclovir—Headache—Hydroxyurea—head and neck cancer	0.00226	0.00226	CcSEcCtD
Valganciclovir—Decreased appetite—Fluorouracil—head and neck cancer	0.00225	0.00225	CcSEcCtD
Valganciclovir—Dysgeusia—Docetaxel—head and neck cancer	0.00224	0.00224	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00224	0.00224	CcSEcCtD
Valganciclovir—Back pain—Docetaxel—head and neck cancer	0.00222	0.00222	CcSEcCtD
Valganciclovir—Pain—Fluorouracil—head and neck cancer	0.00222	0.00222	CcSEcCtD
Valganciclovir—Muscle spasms—Docetaxel—head and neck cancer	0.0022	0.0022	CcSEcCtD
Valganciclovir—Nausea—Hydroxyurea—head and neck cancer	0.00214	0.00214	CcSEcCtD
Valganciclovir—Feeling abnormal—Fluorouracil—head and neck cancer	0.00214	0.00214	CcSEcCtD
Valganciclovir—Anaemia—Docetaxel—head and neck cancer	0.00212	0.00212	CcSEcCtD
Valganciclovir—Urticaria—Fluorouracil—head and neck cancer	0.00206	0.00206	CcSEcCtD
Valganciclovir—Leukopenia—Docetaxel—head and neck cancer	0.00205	0.00205	CcSEcCtD
Valganciclovir—Body temperature increased—Fluorouracil—head and neck cancer	0.00205	0.00205	CcSEcCtD
Valganciclovir—Cough—Docetaxel—head and neck cancer	0.002	0.002	CcSEcCtD
Valganciclovir—Convulsion—Docetaxel—head and neck cancer	0.00199	0.00199	CcSEcCtD
Valganciclovir—Hypertension—Docetaxel—head and neck cancer	0.00198	0.00198	CcSEcCtD
Valganciclovir—Arthralgia—Docetaxel—head and neck cancer	0.00195	0.00195	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00194	0.00194	CcSEcCtD
Valganciclovir—Hypersensitivity—Fluorouracil—head and neck cancer	0.00191	0.00191	CcSEcCtD
Valganciclovir—Dry mouth—Docetaxel—head and neck cancer	0.00191	0.00191	CcSEcCtD
Valganciclovir—Confusional state—Docetaxel—head and neck cancer	0.00189	0.00189	CcSEcCtD
Valganciclovir—Anaphylactic shock—Docetaxel—head and neck cancer	0.00187	0.00187	CcSEcCtD
Valganciclovir—Oedema—Docetaxel—head and neck cancer	0.00187	0.00187	CcSEcCtD
Valganciclovir—Infection—Docetaxel—head and neck cancer	0.00186	0.00186	CcSEcCtD
Valganciclovir—Nervous system disorder—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Valganciclovir—Pruritus—Fluorouracil—head and neck cancer	0.00183	0.00183	CcSEcCtD
Valganciclovir—Thrombocytopenia—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Valganciclovir—Tachycardia—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Valganciclovir—Skin disorder—Docetaxel—head and neck cancer	0.00182	0.00182	CcSEcCtD
Valganciclovir—Anorexia—Docetaxel—head and neck cancer	0.00178	0.00178	CcSEcCtD
Valganciclovir—Diarrhoea—Fluorouracil—head and neck cancer	0.00177	0.00177	CcSEcCtD
Valganciclovir—Hypotension—Docetaxel—head and neck cancer	0.00175	0.00175	CcSEcCtD
Valganciclovir—Dizziness—Fluorouracil—head and neck cancer	0.00171	0.00171	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.0017	0.0017	CcSEcCtD
Valganciclovir—Insomnia—Docetaxel—head and neck cancer	0.00169	0.00169	CcSEcCtD
Valganciclovir—Paraesthesia—Docetaxel—head and neck cancer	0.00168	0.00168	CcSEcCtD
Valganciclovir—Dyspnoea—Docetaxel—head and neck cancer	0.00167	0.00167	CcSEcCtD
Valganciclovir—Somnolence—Docetaxel—head and neck cancer	0.00166	0.00166	CcSEcCtD
Valganciclovir—Vomiting—Fluorouracil—head and neck cancer	0.00165	0.00165	CcSEcCtD
Valganciclovir—Dyspepsia—Docetaxel—head and neck cancer	0.00165	0.00165	CcSEcCtD
Valganciclovir—Dermatitis—Fluorouracil—head and neck cancer	0.00163	0.00163	CcSEcCtD
Valganciclovir—Decreased appetite—Docetaxel—head and neck cancer	0.00163	0.00163	CcSEcCtD
Valganciclovir—Headache—Fluorouracil—head and neck cancer	0.00162	0.00162	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00161	0.00161	CcSEcCtD
Valganciclovir—Fatigue—Docetaxel—head and neck cancer	0.00161	0.00161	CcSEcCtD
Valganciclovir—Pain—Docetaxel—head and neck cancer	0.0016	0.0016	CcSEcCtD
Valganciclovir—Constipation—Docetaxel—head and neck cancer	0.0016	0.0016	CcSEcCtD
Valganciclovir—Feeling abnormal—Docetaxel—head and neck cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Nausea—Fluorouracil—head and neck cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00153	0.00153	CcSEcCtD
Valganciclovir—Abdominal pain—Docetaxel—head and neck cancer	0.00148	0.00148	CcSEcCtD
Valganciclovir—Body temperature increased—Docetaxel—head and neck cancer	0.00148	0.00148	CcSEcCtD
Valganciclovir—Hypersensitivity—Docetaxel—head and neck cancer	0.00138	0.00138	CcSEcCtD
Valganciclovir—Asthenia—Docetaxel—head and neck cancer	0.00134	0.00134	CcSEcCtD
Valganciclovir—Pruritus—Docetaxel—head and neck cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Diarrhoea—Docetaxel—head and neck cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Dizziness—Docetaxel—head and neck cancer	0.00124	0.00124	CcSEcCtD
Valganciclovir—Vomiting—Docetaxel—head and neck cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Dermatitis—Docetaxel—head and neck cancer	0.00118	0.00118	CcSEcCtD
Valganciclovir—Headache—Docetaxel—head and neck cancer	0.00117	0.00117	CcSEcCtD
Valganciclovir—Nausea—Docetaxel—head and neck cancer	0.00111	0.00111	CcSEcCtD
